CAMBRIDGE, Mass. — August 5, 2025 — Leads & Copy — Spero Therapeutics, Inc. (Nasdaq: SPRO) will host a conference call and live audio webcast on Tuesday, August 12, 2025, at 4:30 p.m. ET to report financial results for the second quarter of 2025 and provide a business update.
To access the call, dial 1-844-825-9789 (domestic) or 1-412-317-5180 (international) and refer to conference ID 10200686, or click on this link and request a return call with passcode 0605709. The audio webcast can be accessed live on this link and also on the “Investor Relations” page of the Spero Corporate Website.
Spero Therapeutics is a clinical-stage biopharmaceutical company focused on identifying and developing novel treatments for rare diseases and multi-drug resistant (MDR) bacterial infections with high unmet need. The company is headquartered in Cambridge, Massachusetts.
Spero Investor Relations Contact:
Shai Biran, PhD
IR@sperotherapeutics.com
Spero Media Inquiries:
media@sperotherapeutics.com
